IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

GW Pharmaceuticals PLC

CUSIP: 36197T103 | 867 institutional holders

Quarters

Q2 2024Q1 2022Q2 2021Q1 2021Q4 2020
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

Strategic Investment Solutions, Inc.38
0.0% of portfolio›$8.2K
StyleTurnoverLocationFiled
Strategic Investment Solutions, Inc.
38$8.2K0.0%ETFMediumOrland Park, IL2024-08-30